Chapter 1: Introduction
Schizoaffective disorder is a psychological disorder which comprises both the schizophrenia along with mood disorder. Schizoaffective disorder has two major subtypes’ schizoaffective disorder bipolar type and depressive type .In this study schizophrenia (hallucinations and delusions) and mood disorder (depression and mania) are accessed in MBA students. This study highlights causes, treatment of psychotic and non-psychotic symptoms through bio psychosocial method as mentioned in booklet issued by (Mental Illness Fellowship Victoria, 2008).
From long time there was problem in differentiating schizoaffective disorder from schizophrenia along with mood episodes, but it is now been accepted as separate illness entity so that its entire identity along with symptoms and can be considered and studied for reconceptualization (Malaspina, 2013).This study is based on accessing of schizoaffective disorder among MBA students having aim to develop psychological insight among MBA students. This can be helpful for them in becoming better managers and professional decision makers back upped with strong and stable personality (Nelson, 1959).
In today’s globally competitive and intellectually developed corporate world, managers and decision makers are the heart of this massive body. The managers and decision makers are fighting a war of sustainability not with their guns but with their minds and they are sacrificing a lot for the unpredictable growth of corporate world since many decades. So far history has proven their success in related efforts but it takes huge potential to do so. So far, today’s ever changing corporate world has come up with more difficulties for managers and decision makers comparatively then previous few decades.
Nowadays one cannot play without shaking his/her mind and brainstorming while keeping vision, mission, organizational goals, strategies, and corporate ethics in mind. It is only possible when one would have insight about himself/herself. The problem statement or Aim of this study is to access and identify schizoaffective disorder among potential managers and decision makers and to develop psychological insight among them. Which will be helpful for them in self-improvement and they can perform more professionally in today’s environment.
History has proven that people have not too much stronger essential belief about psychological disorders as compare to the medical disorders, whereas accessing and diagnostic of mental disorder helps in identifying the cause and its removal through useful and affective ways (Ahn, Flanagan, Marsh & Sanislow, 2006).Schizoaffective disorder is a mental disorder and has undergone through different conceptualization eras because the major problem was to differentiate schizoaffective disorder from schizophrenia. Kareplian (1920) has first purposed the clinical reality of frequent overlap of affective and non-affective psychosis in the same individual.
In 1952 first edition of Diagnostic and Statistical Manual of Mental Disorders (DSM) was published in which schizophrenic type and schizoaffective type was discussed.
Ahn, W. K., Flanagan, E. H., Marsh, J. K., & Sanislow, C. A. (2006). Beliefs about essences and the reality of mental disorders. Psychological Science, 17(9), 759-766.
Andrews, G., & Slade, T. (2001). Interpreting scores on the Kessler psychological distress scale (K10). Australian and New Zealand journal of public health, 25(6), 494-497.
Castle, D. J. (2012). Schizoaffective disorder. Advances in psychiatric treatment, 18(1), 32-33.
Craig, R. J., Bivens, A., & Olson, R. (1997). MCMI-III-derived typological analysis of cocaine and heroin addicts. Journal of Personality Assessment, 69(3), 583-595.
Cosoff, S. J., & Julian Hafner, R. (1998). The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Australian and New Zealand Journal of Psychiatry, 32(1), 67-72.
Fitzgerald, P., de Castella, A., Arya, D., Simons, W. R., Eggleston, A., Meere, S., & Kulkarni, J. (2009). The cost of relapse in schizophrenia and schizoaffective disorder. Australasian Psychiatry, 17(4), 265-272.
Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004). The concordance of self-report with other measures of medication adherence: a summary of the literature. Medical care, 42(7), 649-652.
Harrow, M., Goldberg, J. F., Grossman, L. S., & Meltzer, H. Y. (1990). Outcome in manic disorders: a naturalistic follow-up study. Archives of General Psychiatry, 47(7), 665-671.
Jeffs, S. (2008). Be loyal to wellness. Mental Illness Fellowship Victoria. Disponível em:< file:///C:/Users/Ana% 20Silvia/Downloads/Be% 20loyal% 20to% 20wellness. pdf.
Kentros, M. K., Terkelsen, K., Hull, J., Smith, T. E., & Goodman, M. (1997). The relationship between personality and quality of life in persons with schizoaffective disorder and schizophrenia. Quality of Life Research, 6(2), 0-0.
Landin-Romero, R., Canales-Rodríguez, E. J., Kumfor, F., Moreno-Alcázar, A., Madre, M., Maristany, T., … & Amann, B. L. (2016). Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder. Australian and New Zealand Journal of Psychiatry, 0004867416631827.
Lehman, E. E. (2012). The Case of Rose Schizoaffective Disorder and Secondary Anorexia Nervosa in Late Life. Clinical Case Studies, 11(5), 348-360.
Malaspina, D., Owen, M. J., Heckers, S., Tandon, R., Bustillo, J., Schultz, S., … & Van Os, J. (2013). Schizoaffective disorder in the DSM-5. Schizophrenia research, 150(1), 21-25.
Moncrieff, J., Azam, K., Johnson, S., Marston, L., Morant, N., Darton, K., & Wood, N. (2016). Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication. BMC psychiatry, 16(1), 205.
Ritsner, M. S., Arbitman, M., Lisker, A., & Ponizovsky, A. M. (2012). Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors. Quality of Life Research, 21(6), 1075-1084.